HIRONIC announces Korean authorization for MIGLOU microwave platform
Source publication date
Site published
MIGLOU uses the manufacturer’s FIM microwave design. Its product page describes face/body handpieces and contact cooling. Surface cooling should not be confused with cryolipolysis.
The verified news is the manufacturer’s announcement. The exact Korean certificate, permitted indication and current status were not independently retrieved from the regulator. FDA or CE histories for other HIRONIC models cannot be transferred to MIGLOU.
Summary
HIRONIC announced MFDS authorization for MIGLOU on July 9. The company positions the 2.45 GHz microwave platform for skin tightening and contouring.
Editorial view
Editorial view: this Korean platform illustrates why procurement comparisons must distinguish microwave, electrode-based RF, ultrasound, fat cooling and muscle stimulation. Model-specific authorized use should be checked first.
Evidence and limitations
A company announcement is not independent clinical validation. It does not establish weight-loss or obesity treatment, quantified fat reduction, pain-free use or zero risk/downtime.